Hepatitis C virus (HCV) genotype analysis in apparently healthy anti- HCV-positive Parisian blood donors

Transfusion

Volumn 36, Issue 6, 1996, Pages 552-558

  Stuyver, L ^a   Fretz, C ^b   Esquivel, C ^c,d   Boudifa, A ^b   Jaulmes, D ^b   Azar, N ^b   Lunel, F ^b   Leroux Roels, G ^c   Maertens, G ^a   Fournel, J J ^b  

^a INNOGENETICS   (Belgium)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FRANCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; VIRUS DETECTION; VIRUS TYPING;

EID: 8944248274     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36696269516.x     Document Type: Article

References (40)

1. Choo QL, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991;88:2451-5.
2. Van der Poel CL, Reesink HW, Lelie PN, et al. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet 1989;2:297-8.
3. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
4. Van der Poel CL, Cuypers HT, Reesink HW, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991;337:317-9.
5. Das PC, Heethuis A, McShine RL, Sibinga CT. Supplemental HCV antibody assay in blood donors by RIBA and line immunoassay. Transfus Med 1994;4:173-5.
6. Dussaix E, Charnaux N, Laurent-Puig P, et al. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody. J Clin Microbiol 1994;32:2071-5.
7. Zaaijer HL, Vrielink H, van Exel-Oehlers PJ, et al. Confirmation of hepatitis C infection: a comparison of five immunoblot assays. Transfusion 1994;34:603-7.
8. Bukh J, Wantzin P, Krogsgaard K, et al. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J Infect Dis 1993;168:1343-8.
9. Garson JA, Ring C, Tuke P, Tedder RS. Enhanced detection by PCR of hepatitis C virus RNA (letter). Lancet 1990;336:878-9.
10. Sugitani M, Inchauspé G, Shindo M, Prince AM. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 1992;339:1018-9.
11. Kroes AC, de Man RA, Niesters HG, et al. Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only. J Hepatol 1994;21:1113-5.
12. Hagiwara H, Hayashi N, Mita E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993;104:877-83.
13. Goodrick MJ, Gray SF, Rouse AM, et al. Hepatitis C (HCV)-positive blood donors in south-west England: a case control study. Transfus Med 1994;4:113-9.
14. Suzuki K, Mizokami M, Lau JY, et al. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J Infect Dis 1994;170:1575-8.
15. Moore SB, Kruger JR, Rakela J, et al. Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factors. Transfusion 1995;35:308-12.
16. Stuyver L, Rossau R, Wyseur A, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993;74:1093-102.
17. Stuyver L, Wyseur A, van Arnhem W, et al. Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples. Virus Res 1995;38;137-57.
18. Felsenstein J. PHYLIP (Phylogeny Inference Package) version 3.5c. Seattle, WA: Department of Genetics, University of Washington, 1993.
19. Van Doorn LJ, Kleter GE, Stuyver L, et al. Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countries. J Gen Virol 1995;76:1871-6.
20. Qu D, Hantz O, Gouy M, et al. Heterogeneity of hepatitis C virus genotypes in France. J Gen Virol 1994;75:1063-70.
21. Giannini C, Thiers V, Nousbaum JB, et al. Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes. J Hepatol 1995;23:246-53.
22. Van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-9.
23. Manzini P, Calvo PL, Abate ML, et al. Asymptomatic anti-HCV seropositive subjects include patients with chronic active hepatitis and individuals with normal liver: can we distinguish them? (letter). J Hepatol 1994;21:136-7.
24. Yuki N, Hayashi N, Kamada T. HCV viraemia and liver injury in symptom-free blood donors (letter). Lancet 1993;342:444.
25. Rossini A, Gazzola GB, Ravaggi A, et al. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels. Transfusion 1995;35:108-11.
26. Alberti A, Morsica G, Chemello L, et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 1992;340:697-8.
27. Esteban JI, Lopez-Talavera JC, Genesca J, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991;115:443-9.
28. Naito M, Hayashi N, Hagiwara H, et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994;19:871-5.
29. Zaaijer HL, Cuypers HT, Reesink HW, et al. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993;341:722-4.
30. Prieto M, Olaso V, Verdu C, et al. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology 1995;22:413-7.
31. McOmish F, Chan SW, Dow BC, et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993;33:7-13.
32. Pawlotsky JM, Roudot-Thoraval F, Pellet C, et al. Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns. J Clin Microbiol 1995;33:1357-9.
33. Aoki SK, Holland PV, Fernando LP, et al. Evidence of hepatitis in patients receiving transfusions of blood components containing antibody to hepatitis C. Blood 1993;82:1000-5.
34. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 1995;345:289-91.
35. Osmond DH, Padian NS, Sheppard HW, et al. Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA 1993;269:361-5.
36. Chang TT, Liou TC, Young KC, et al. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 1994;42:91-6.
37. Power JP, Lawlor E, Davidson F, et al. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995;345:1211-3.
38. Tumminelli F, Marcellin P, Rizzo S, et al. Shaving as potential source of hepatitis C virus infection (letter). Lancet 1995;345:658.
39. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;171:1607-10.
40. Gournay J, Marcellin P, Martinot-Peignoux M, et al. Hepatitis C virus genotypes in French blood donors. J Med Virol 1995;45:399-404.